News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
581,185 Results
Type
Article (19095)
Company Profile (166)
Press Release (561921)
Multimedia
Podcasts (78)
Webinars (13)
Section
Business (198409)
Career Advice (703)
Deals (30749)
Drug Delivery (89)
Drug Development (65655)
Employer Resources (54)
FDA (12403)
Job Trends (11100)
News (287882)
Policy (24150)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (821)
Accelerated approval (43)
ADA (26)
Adcomms (10)
Allergies (143)
Alliances (41817)
ALS (143)
Alzheimer's disease (1271)
Antibody-drug conjugate (ADC) (350)
Approvals (13030)
Artificial intelligence (509)
ASCO (219)
Autoimmune disease (251)
Automation (40)
Bankruptcy (319)
Best Places to Work (8370)
BIO (47)
BIOSECURE Act (10)
Biosimilars (190)
BioSpace Insights (77)
Biotechnology (102)
Bladder cancer (155)
Brain cancer (55)
Breast cancer (603)
Cancer (4473)
Cardiovascular disease (352)
Career advice (608)
Career pathing (15)
CAR-T (218)
CDC (8)
Celiac Disease (1)
Cell therapy (611)
Cervical cancer (41)
Clinical research (58862)
Collaboration (1726)
Commercialization (4)
Company closure (2)
Compensation (1476)
Complete response letters (61)
COVID-19 (1285)
CRISPR (82)
C-suite (1049)
Cystic fibrosis (126)
Data (6621)
Decentralized trials (1)
Denatured (23)
Depression (125)
Dermatology (67)
Diabetes (441)
Diagnostics (4826)
Digital health (44)
Diversity (3)
Diversity, equity & inclusion (16)
Drug discovery (269)
Drug pricing (126)
Drug shortages (15)
Duchenne muscular dystrophy (230)
Earnings (81366)
Editorial (25)
Employer branding (5)
Employer resources (50)
Events (99220)
Executive appointments (962)
FDA (15553)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (27)
Funding (1226)
Gene editing (164)
Generative AI (35)
Gene therapy (459)
GLP-1 (674)
Government (2016)
Grass and pollen (5)
Guidances (332)
Healthcare (11044)
Hematology (128)
HIV (55)
Huntington's disease (28)
IgA nephropathy (99)
Immunology and inflammation (168)
Immuno-oncology (76)
Indications (195)
Infectious disease (1517)
Inflammatory bowel disease (173)
Inflation Reduction Act (9)
Influenza (97)
Intellectual property (296)
Interviews (94)
IPO (13978)
IRA (33)
Job creations (3104)
Job search strategy (550)
JPM (29)
Kidney cancer (20)
Labor market (39)
Layoffs (253)
Leadership (11)
Legal (6588)
Licensing (8)
Liver cancer (55)
Longevity (22)
Lung cancer (633)
Lymphoma (343)
Machine learning (35)
Management (18)
Manufacturing (909)
Marketing (12)
MASH (164)
Medical affairs (1)
Medical device (9257)
Medtech (9406)
Mergers & acquisitions (17942)
Metabolic disorders (1065)
mRNA (108)
Multiple sclerosis (139)
NASH (15)
Neurodegenerative disease (299)
Neuropsychiatric disorders (70)
Neuroscience (2431)
Neurotech (1)
NextGen: Class of 2026 (3897)
Non-profit (1260)
Now hiring (24)
Obesity (427)
Opinion (158)
Ovarian cancer (175)
Pain (242)
Pancreatic cancer (226)
Parkinson's disease (278)
Partnered (21)
Patents (581)
Patient recruitment (594)
Peanut (39)
People (50685)
Pharmaceutical (45)
Pharmacy benefit managers (23)
Phase 1 (18152)
Phase 2 (25887)
Phase 3 (19201)
Pipeline (8665)
Policy (165)
Postmarket research (2127)
Preclinical (7535)
Press Release (49)
Prostate cancer (236)
Psychedelics (31)
Radiopharmaceuticals (269)
Rare diseases (854)
Real estate (4461)
Recruiting (20)
Regulatory (19736)
Reports (27)
Research institute (959)
Resumes & cover letters (95)
Rett syndrome (42)
RNA editing (12)
RSV (53)
Schizophrenia (145)
Series A (222)
Series B (157)
Service/supplier (5)
Sickle cell disease (98)
Special edition (11)
Spinal muscular atrophy (113)
Sponsored (15)
Startups (2783)
State (2)
Stomach cancer (8)
Supply chain (95)
Tariffs (71)
The Weekly (53)
Vaccines (510)
Venture capital (56)
Weight loss (227)
Women's health (101)
Worklife (4)
Date
Today (43)
Last 7 days (536)
Last 30 days (1983)
Last 365 days (23143)
2026 (14728)
2025 (23301)
2024 (27244)
2023 (31376)
2022 (40752)
2021 (43351)
2020 (39855)
2019 (29680)
2018 (22622)
2017 (24683)
2016 (23531)
2015 (29427)
2014 (25670)
2013 (22071)
2012 (24094)
2011 (24438)
2010 (23670)
Location
Africa (468)
Alabama (81)
Alaska (2)
Arizona (330)
Arkansas (13)
Asia (30155)
Australia (4147)
California (12604)
Canada (3441)
China (1032)
Colorado (508)
Connecticut (463)
Delaware (272)
Europe (54644)
Florida (1924)
Georgia (404)
Hawaii (3)
Idaho (49)
Illinois (852)
India (95)
Indiana (553)
Iowa (15)
Japan (557)
Kansas (119)
Kentucky (36)
Louisiana (30)
Maine (28)
Maryland (1359)
Massachusetts (8660)
Michigan (324)
Minnesota (601)
Mississippi (5)
Missouri (104)
Montana (27)
Nebraska (16)
Nevada (116)
New Hampshire (68)
New Jersey (3175)
New Mexico (18)
New York (3098)
North Carolina (1509)
North Dakota (4)
Northern California (6314)
Ohio (301)
Oklahoma (16)
Oregon (31)
Pennsylvania (2398)
Puerto Rico (26)
Rhode Island (36)
South America (732)
South Carolina (79)
South Dakota (1)
Southern California (5191)
Tennessee (147)
Texas (2021)
United States (42685)
Utah (384)
Vermont (1)
Virginia (264)
Washington D.C. (51)
Washington State (980)
West Virginia (2)
Wisconsin (103)
Wyoming (1)
581,185 Results for "agios pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Sickle cell disease
Agios axes next-gen sickle cell candidate after it fails to best Novo’s asset
Agios Pharmaceuticals’ sickle cell disease candidate didn’t prove any better than Novo Nordisk’s investigational PK activator or the biopharma’s own asset that is currently under FDA review for the indication.
July 21, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Agios Reports Second Quarter 2026 Financial Results and Provides Business Update
July 30, 2026
·
13 min read
Press Releases
Agios Provides Update on Phase 2 Trial of Tebapivat in Sickle Cell Disease
July 21, 2026
·
7 min read
Press Releases
U.S. FDA Grants Priority Review to Agios’ sNDA for Mitapivat in Sickle Cell Disease
July 7, 2026
·
15 min read
Press Releases
Agios to Host Second Quarter 2026 Financial Results Conference Call and Webcast on July 30 at 8:00 a.m. ET
June 29, 2026
·
2 min read
Press Releases
Agios’ PYRUKYND® (mitapivat) Approved in the European Union for Adults with Thalassemia
May 24, 2026
·
15 min read
Press Releases
Agios Provides Update on Phase 2b Trial of Tebapivat in Lower-Risk Myelodysplastic Syndromes
May 29, 2026
·
6 min read
Press Releases
Agios Reports First Quarter 2026 Financial Results and Provides Business Update
April 29, 2026
·
11 min read
Press Releases
Agios Enters Exclusive Global License Agreement with Oscotec to Develop and Commercialize Next-Generation SYK Inhibitor Cevidoplenib
June 1, 2026
·
12 min read
Press Releases
Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease
May 12, 2026
·
10 min read
1 of 58,119
Next
